Key Takeaways New state-of-the-art facility and expansion into branded generics and CDMO deepen client relationships and position the company for sustainable global revenue growth. Backward integration, cost-plus pricing, and R&D into specialized products are expected to drive margin improvement and long-term earnings stability.Read more
